# Craig Davis

> Craig Davis is the President and CEO of NovaScan, a Chicago-based clinical-stage oncology company building a low-cost, point-of-care platform that uses bioimpedance and machine learning to detect and stratify cancer in real time. A medtech executive and investor with more than two decades of experience, he has raised over $20 million for NovaScan, secured a CPRIT grant, and helped steer clinical trials in skin, lung, breast, GI and pancreatic cancers. Earlier in his career he helped shape companies including New Aera (acquired by Inogen), Merge Healthcare (IPO; later acquired by IBM), and OrthoScan, and was a partner at healthcare investment bank Healthios.

- **Role:** President and CEO at NovaScan
- **Organizations:** NovaScan, Healthios, LaSalle Investments, New Aera, OrthoScan, Merge Healthcare
- **Nationality:** American
- **Education:** MBA, Kellogg School of Management, Northwestern University, MS in Engineering, Northwestern University, BS in Mechanical Engineering, Washington University in St. Louis
- **Known for:** Raised over $20 million in capital for NovaScan, Secured a CPRIT (Cancer Prevention and Research Institute of Texas) grant, Drove development of an AI and bioimpedance-based platform for rapid intraoperative cancer assessment

## Career timeline

- **—** — Earned a BS in Mechanical Engineering from Washington University in St. Louis
- **—** — Earned an MS in Engineering and an MBA from Northwestern University (Kellogg)
- **—** — Partner at LaSalle Investments, which co-founded Merge Healthcare and OrthoScan
- **—** — Served on a GTCR-backed team executing a urologic device roll-up
- **—** — Partner at Healthios, a healthcare investment bank founded by former Baxter CEO Vern Loucks
- **—** — Contributed to the formation of New Aera (later acquired by Inogen)
- **—** — Became President and CEO of NovaScan, a clinical-stage oncology diagnostics company
- **2022** — Named a WiSys Carl E. Gulbrandsen Innovator of the Year with co-leader Dr. William Gregory
- **2024** — Presented NovaScan at the LSI USA '24 Emerging Medtech Summit

## Achievements

- Raised over $20 million in capital for NovaScan
- Secured a CPRIT (Cancer Prevention and Research Institute of Texas) grant
- Drove development of an AI and bioimpedance-based platform for rapid intraoperative cancer assessment
- Executed multiple strategic partnerships and advanced clinical trials across skin, lung, breast, GI and pancreatic cancers
- Named 2022 WiSys Innovator of the Year
- Earlier helped build Merge Healthcare (IPO; later acquired by IBM for ~$1 billion) and OrthoScan (acquired by ATON GmbH)

## Latest updates

- **2024-03** — Presented NovaScan's ex vivo and in vivo cancer detection platform at LSI USA '24.
- **2021-11** — NovaScan's most recent disclosed funding round (Series B, part of $15.6M+ total raised).

## Links

- Website: https://novascaninc.com
- LinkedIn: http://www.linkedin.com/in/craig-davis-4023a
- YouTube: https://www.youtube.com/watch?v=kvaICdF527U

---

Profile page: https://yespress.io/craig-davis
Published by YesPress — https://yespress.io
Last updated: 2026-07-02